Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty (EPCATIII)

NCT04075240 is registered in ClinicalTrials.gov with Sudeep Shivakumar as lead sponsor.

NCT NCT04075240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty (EPCATIII)
Lead sponsor
Sudeep Shivakumar
Phase
Phase 3
Overall status
Completed
Start date
February 4, 2021
Completion date
June 10, 2026
Enrollment
5,429 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism